Deltex Medical Group PLC (LSE:DEMG) - Share price - Overview

Stock Report

Deltex Medical Group PLC DEMG

Last Price
GBX1.30

Day Change
0.00|0.00%

As of 18/06/2018
13:28:18 BST | GBX
Minimum 15 Minutes Delay.

Last Close1.30p
Day Range1.25 - 1.31
Mkt Cap6.41Mil
52-Wk Range0.75 - 4.17
Yield %-
ISINGB0059337583
Volume138,006
P/E-1.86
P/S0.01
P/CF-0.04

Share Price

Total Returns 18/06/2018

 Chg (%)  
More ...
Deltex Medical Group PLC4.00 
FTSE 100 TR GBP-1.59
 
Financials
201520162017
More ...
Income Statement
Turnover6.416.335.87
Operating Profit-3.33-2.37-1.94
Net Profit-3.46-2.38-2.00
Reported EPS-1.60-0.90-0.70
Balance Sheet
Current Assets4.133.953.12
Non Current Assets2.582.832.76
Total Assets6.716.785.88
Current Liabilities4.633.273.46
Total Liabilities4.784.364.58
Total Equity1.922.421.30
Cash Flow
Operating Cash Flow-1.84-1.98-1.04
Net Change in Cash-2.36-0.05-0.35
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
15/02/2018Exercise of OptionMr. Ewan Alastair Phillips1.00800,0008,000.00
22/01/2018PurchaseMr. Nigel John Keen1.2514,400,000180,000.00
27/07/2017PurchaseMr. Nigel John Keen3.381,629,63055,000.00

Company Profile

Deltex Medical Group PLC develops, designs, manufactures and markets medical equipment that deploys low-frequency ultrasound to visualise and measure blood flow in the central circulation. The company's segments are Probes and Other.

Sector

Medical Devices

Index

FTSE AIM All-Share

Next Event 20/06/2018

Annual General Meeting
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-80.78
Op Mrgn-0.33
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive Director, ChairmanMr. Nigel John Keen
Executive Director, Chief Executive OfficerMr. Ewan Alastair Phillips
Executive Director, Group Finance Director and Company SecretaryMr. Jonathan David Shaw
Non-Executive DirectorMr. Julian Cazalet
Non-Executive DirectorMr. Mark Alexander Wippell
Non-Executive DirectorProf Sir Duncan Kirkbride Nichol CBE
Non-Executive DirectorMr. Christopher Michael Jones
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.